Centre for Faecal Microbiota Transplantation at Aarhus University Hospital (CEFTA) was established in 2018 following a 17.2 mio DKK investment from Innovation Fund Denmark.
The aim of CEFTA is to implement FMT as a standard treatment for recurrent Clostridioides difficile infection in Denmark.
The mission is to save lives by modulating the intestinal microbiota.
Saving lives through modulation of communities of intestinal microbiota.
To develop and consolidate microbiota-based treatments of life-threatening diseases.
Partner leader in CEFTA: Tine Rask Licht